Agile Therapeutics is a women's healthcare company. The company's primary product candidate, Twirla, also known as AG200-15, is a once-weekly prescription combination hormonal contraceptive patch that is at the end of clinical development. Twirla is a combined hormonal contraceptives patch that contains the active ingredients ethinyl estradiol, which is a synthetic estrogen, and levonorgestrel, which is a type of progestin, a synthetic steroid hormone. The company also has a pipeline of other transdermal contraceptive products, including AG200-ER, which is a regimen designed to allow a woman to extend the length of her cycle, and AG200-SP, which is a regimen designed to provide shorter lighter periods.

Atlanticus Holdings is a holding company. Through its subsidiaries, the company provides various credit and related financial services and products. The company has two segments: Credit and Other Investments, whereby the company supports lenders who originate consumer loan products that include retail credit and credit cards marketed through various channels, including retail point-of-sale, direct mail solicitation, and partnerships with third parties; and Auto Finance, which purchases and/or services loans secured by automobiles from or for, and also provides floor plan financing for, a pre-qualified network of automotive dealers and automotive finance companies in the buy-here, pay-here, used car business.

TrovaGene is a clinical-stage, oncology therapeutics company, taking a precision medicine approach to develop targeted therapies for the treatment of patients with leukemias, lymphomas and solid tumor cancers. The company's drug candidate, onvansertib, is an oral and highly-selective Polo-like Kinase 1 (PLK1) adenosine triphosphate competitive inhibitor. PLK1 is essential for regulating the cell division and maintaining genome stability in mitosis (cell division), spindle assembly, and DNA damage response. The company's intellectual property and proprietary technology enables it to analyze circulating tumor DNA and clinically actionable markers for predicting response to cancer therapies.

Solid Biosciences is engaged in the treatment of Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease primarily affecting boys, with symptoms that manifest between three and five years of age. The company's primary gene transfer candidate, SGT-001 is designed to address the underlying genetic cause of DMD by delivering a synthetic transgene that produces dystrophin-like protein that is only expressed in muscles of the body, including cardiac and respiratory muscles. The company's portfolio also includes an initial disease modifying candidate, Anti-LTBP4, a monoclonal antibody designed to reduce fibrosis and inflammation by targeting and stabilizing the LTBP4 protein.

Sumo Group is engaged in the development of video games providing both turnkey and co-development solutions. Co.'s development solution, includes initial concept and pre-production, production and development, and post-release support. Co. develops games across all console platforms, PC, handheld and mobile devices.

Support.com is engaged in outsourced call center and direct-to-consumer and small business technical support solutions. The company provides outsourced call center tech support services, cloud-based call center software, and tech support and anti-malware software. The company delivers support solutions, including presale and post-sale support across all devices in the connected home. Designed for both the consumer and small and medium-sized businesses end-user markets, the company's programs include a range of services for connected devices, including pre-purchase concierge advice, device set-up and troubleshooting, inter-operability problem resolution, and virus and malware removal.

Veritiv is a business-to-business distributor of packaging, facility solutions, print and publishing products and services. Co has the following reportable segments: Packaging, which provides standard as well as custom packaging solutions; Facility Solutions, which sources and sells cleaning, break-room and other supplies such as towels, tissues, wipers and dispensers, can liners, commercial cleaning chemicals, soaps and sanitizers; Print, which sells and distributes commercial printing, writing, copying, digital, specialty products, graphics consumables and graphics equipment; and Publishing and Print Management, which sells and distributes coated and uncoated commercial printing papers.